Per Stirling Capital Management, Llc. Abbott Laboratories Transaction History
Per Stirling Capital Management, Llc.
- $721 Billion
- Q3 2024
A detailed history of Per Stirling Capital Management, Llc. transactions in Abbott Laboratories stock. As of the latest transaction made, Per Stirling Capital Management, Llc. holds 5,376 shares of ABT stock, worth $614,100. This represents 0.09% of its overall portfolio holdings.
Number of Shares
5,376
Previous 6,871
21.76%
Holding current value
$614,100
Previous $714 Million
14.15%
% of portfolio
0.09%
Previous 0.11%
Shares
8 transactions
Others Institutions Holding ABT
# of Institutions
3,186Shares Held
1.3BCall Options Held
8.74MPut Options Held
8.08M-
Vanguard Group Inc Valley Forge, PA168MShares$19.2 Billion0.35% of portfolio
-
Black Rock Inc. New York, NY131MShares$15 Billion0.31% of portfolio
-
State Street Corp Boston, MA76.7MShares$8.76 Billion0.36% of portfolio
-
Capital International Investors Los Angeles, CA65.7MShares$7.51 Billion1.49% of portfolio
-
Capital Research Global Investors Los Angeles, CA53.3MShares$6.09 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $200B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...